Aclaris halts work on its experimental rheumatoid arthritis drug after clinical trial failure
Aclaris will discontinue further development of the drug candidate, including halting enrollment of its ongoing phase 2 trial targeting psoriatic arthritis.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: John George Source Type: news
More News: Arthritis | Clinical Trials | Health Management | Pharmaceuticals | Psoriatic Arthritis | Rheumatoid Arthritis | Rheumatology